ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Mesenchymal Stem Cell Injection Market Research Report 2024
Published Date: August 2024
|
Report Code: QYRE-Auto-5F18046
Home | Market Reports | Science| Biological Sciences
Global Mesenchymal Stem Cell Injection Market Research Report 2024
BUY CHAPTERS

Global Mesenchymal Stem Cell Injection Market Research Report 2024

Code: QYRE-Auto-5F18046
Report
August 2024
Pages:79
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
ANTEROGEN CO LTD
PHARMICELL
MediPost Co Ltd
Osiris Therapeutics
Takeda
Stempeutics
JCR Pharmaceuticals
Chiesi Farmaceutici

Mesenchymal Stem Cell Injection Market

Mesenchymal stem cells (MSCs) are multipotent stem cells that can separate into various cell types, including: Bone cells, called osteoblasts. Cartilage cells, termed chondrocytes. Muscle cells, called myocytes. Fat cells that give rise to marrow adipose tissue, called adipocytes. Mesenchymal stem cells (MSCs) are used to treat diseases such as osteoarthritis, osteogenesis imperfecta, Crohn's Disease, Multiple Sclerosis, Parkinson's, and many others.
The global Mesenchymal Stem Cell Injection market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Mesenchymal Stem Cell Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Mesenchymal Stem Cell Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Mesenchymal Stem Cell Injection include Anterogen, Pharmicell, Medipost, Osiris Therapeutics, Takeda, Stempeutics, JCR Pharmaceuticals, CHIESI Farmaceutici, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Mesenchymal Stem Cell Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mesenchymal Stem Cell Injection.
The Mesenchymal Stem Cell Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Mesenchymal Stem Cell Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Mesenchymal Stem Cell Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Mesenchymal Stem Cell Injection Market Report

Report Metric Details
Report Name Mesenchymal Stem Cell Injection Market
Segment by Type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Anterogen, Pharmicell, Medipost, Osiris Therapeutics, Takeda, Stempeutics, JCR Pharmaceuticals, CHIESI Farmaceutici
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Mesenchymal Stem Cell Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Mesenchymal Stem Cell Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Mesenchymal Stem Cell Injection Market report?

Ans: The main players in the Mesenchymal Stem Cell Injection Market are Anterogen, Pharmicell, Medipost, Osiris Therapeutics, Takeda, Stempeutics, JCR Pharmaceuticals, CHIESI Farmaceutici

What are the Application segmentation covered in the Mesenchymal Stem Cell Injection Market report?

Ans: The Applications covered in the Mesenchymal Stem Cell Injection Market report are Tissue Repair, Immunomodulation

What are the Type segmentation covered in the Mesenchymal Stem Cell Injection Market report?

Ans: The Types covered in the Mesenchymal Stem Cell Injection Market report are Autologous Source, Allogeneic Source

Recommended Reports

Cell Therapy Markets

Stem Cell Therapies

Regenerative Medicine

1 Mesenchymal Stem Cell Injection Market Overview
1.1 Product Definition
1.2 Mesenchymal Stem Cell Injection by Type
1.2.1 Global Mesenchymal Stem Cell Injection Market Value Comparison by Type (2024-2030)
1.2.2 Autologous Source
1.2.3 Allogeneic Source
1.3 Mesenchymal Stem Cell Injection by Application
1.3.1 Global Mesenchymal Stem Cell Injection Market Value by Application (2024-2030)
1.3.2 Tissue Repair
1.3.3 Immunomodulation
1.4 Global Mesenchymal Stem Cell Injection Market Size Estimates and Forecasts
1.4.1 Global Mesenchymal Stem Cell Injection Revenue 2019-2030
1.4.2 Global Mesenchymal Stem Cell Injection Sales 2019-2030
1.4.3 Global Mesenchymal Stem Cell Injection Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Mesenchymal Stem Cell Injection Market Competition by Manufacturers
2.1 Global Mesenchymal Stem Cell Injection Sales Market Share by Manufacturers (2019-2024)
2.2 Global Mesenchymal Stem Cell Injection Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Mesenchymal Stem Cell Injection Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Mesenchymal Stem Cell Injection, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Mesenchymal Stem Cell Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Mesenchymal Stem Cell Injection, Product Type & Application
2.7 Global Key Manufacturers of Mesenchymal Stem Cell Injection, Date of Enter into This Industry
2.8 Global Mesenchymal Stem Cell Injection Market Competitive Situation and Trends
2.8.1 Global Mesenchymal Stem Cell Injection Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Mesenchymal Stem Cell Injection Players Market Share by Revenue
2.8.3 Global Mesenchymal Stem Cell Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Mesenchymal Stem Cell Injection Market Scenario by Region
3.1 Global Mesenchymal Stem Cell Injection Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Mesenchymal Stem Cell Injection Sales by Region: 2019-2030
3.2.1 Global Mesenchymal Stem Cell Injection Sales by Region: 2019-2024
3.2.2 Global Mesenchymal Stem Cell Injection Sales by Region: 2025-2030
3.3 Global Mesenchymal Stem Cell Injection Revenue by Region: 2019-2030
3.3.1 Global Mesenchymal Stem Cell Injection Revenue by Region: 2019-2024
3.3.2 Global Mesenchymal Stem Cell Injection Revenue by Region: 2025-2030
3.4 North America Mesenchymal Stem Cell Injection Market Facts & Figures by Country
3.4.1 North America Mesenchymal Stem Cell Injection Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Mesenchymal Stem Cell Injection Sales by Country (2019-2030)
3.4.3 North America Mesenchymal Stem Cell Injection Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Mesenchymal Stem Cell Injection Market Facts & Figures by Country
3.5.1 Europe Mesenchymal Stem Cell Injection Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Mesenchymal Stem Cell Injection Sales by Country (2019-2030)
3.5.3 Europe Mesenchymal Stem Cell Injection Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Mesenchymal Stem Cell Injection Market Facts & Figures by Region
3.6.1 Asia Pacific Mesenchymal Stem Cell Injection Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Mesenchymal Stem Cell Injection Sales by Region (2019-2030)
3.6.3 Asia Pacific Mesenchymal Stem Cell Injection Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Mesenchymal Stem Cell Injection Market Facts & Figures by Country
3.7.1 Latin America Mesenchymal Stem Cell Injection Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Mesenchymal Stem Cell Injection Sales by Country (2019-2030)
3.7.3 Latin America Mesenchymal Stem Cell Injection Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Mesenchymal Stem Cell Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Mesenchymal Stem Cell Injection Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Mesenchymal Stem Cell Injection Sales by Country (2019-2030)
3.8.3 Middle East and Africa Mesenchymal Stem Cell Injection Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Mesenchymal Stem Cell Injection Sales by Type (2019-2030)
4.1.1 Global Mesenchymal Stem Cell Injection Sales by Type (2019-2024)
4.1.2 Global Mesenchymal Stem Cell Injection Sales by Type (2025-2030)
4.1.3 Global Mesenchymal Stem Cell Injection Sales Market Share by Type (2019-2030)
4.2 Global Mesenchymal Stem Cell Injection Revenue by Type (2019-2030)
4.2.1 Global Mesenchymal Stem Cell Injection Revenue by Type (2019-2024)
4.2.2 Global Mesenchymal Stem Cell Injection Revenue by Type (2025-2030)
4.2.3 Global Mesenchymal Stem Cell Injection Revenue Market Share by Type (2019-2030)
4.3 Global Mesenchymal Stem Cell Injection Price by Type (2019-2030)
5 Segment by Application
5.1 Global Mesenchymal Stem Cell Injection Sales by Application (2019-2030)
5.1.1 Global Mesenchymal Stem Cell Injection Sales by Application (2019-2024)
5.1.2 Global Mesenchymal Stem Cell Injection Sales by Application (2025-2030)
5.1.3 Global Mesenchymal Stem Cell Injection Sales Market Share by Application (2019-2030)
5.2 Global Mesenchymal Stem Cell Injection Revenue by Application (2019-2030)
5.2.1 Global Mesenchymal Stem Cell Injection Revenue by Application (2019-2024)
5.2.2 Global Mesenchymal Stem Cell Injection Revenue by Application (2025-2030)
5.2.3 Global Mesenchymal Stem Cell Injection Revenue Market Share by Application (2019-2030)
5.3 Global Mesenchymal Stem Cell Injection Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Anterogen
6.1.1 Anterogen Company Information
6.1.2 Anterogen Description and Business Overview
6.1.3 Anterogen Mesenchymal Stem Cell Injection Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Anterogen Mesenchymal Stem Cell Injection Product Portfolio
6.1.5 Anterogen Recent Developments/Updates
6.2 Pharmicell
6.2.1 Pharmicell Company Information
6.2.2 Pharmicell Description and Business Overview
6.2.3 Pharmicell Mesenchymal Stem Cell Injection Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Pharmicell Mesenchymal Stem Cell Injection Product Portfolio
6.2.5 Pharmicell Recent Developments/Updates
6.3 Medipost
6.3.1 Medipost Company Information
6.3.2 Medipost Description and Business Overview
6.3.3 Medipost Mesenchymal Stem Cell Injection Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Medipost Mesenchymal Stem Cell Injection Product Portfolio
6.3.5 Medipost Recent Developments/Updates
6.4 Osiris Therapeutics
6.4.1 Osiris Therapeutics Company Information
6.4.2 Osiris Therapeutics Description and Business Overview
6.4.3 Osiris Therapeutics Mesenchymal Stem Cell Injection Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Osiris Therapeutics Mesenchymal Stem Cell Injection Product Portfolio
6.4.5 Osiris Therapeutics Recent Developments/Updates
6.5 Takeda
6.5.1 Takeda Company Information
6.5.2 Takeda Description and Business Overview
6.5.3 Takeda Mesenchymal Stem Cell Injection Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Takeda Mesenchymal Stem Cell Injection Product Portfolio
6.5.5 Takeda Recent Developments/Updates
6.6 Stempeutics
6.6.1 Stempeutics Company Information
6.6.2 Stempeutics Description and Business Overview
6.6.3 Stempeutics Mesenchymal Stem Cell Injection Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Stempeutics Mesenchymal Stem Cell Injection Product Portfolio
6.6.5 Stempeutics Recent Developments/Updates
6.7 JCR Pharmaceuticals
6.7.1 JCR Pharmaceuticals Company Information
6.7.2 JCR Pharmaceuticals Description and Business Overview
6.7.3 JCR Pharmaceuticals Mesenchymal Stem Cell Injection Sales, Revenue and Gross Margin (2019-2024)
6.7.4 JCR Pharmaceuticals Mesenchymal Stem Cell Injection Product Portfolio
6.7.5 JCR Pharmaceuticals Recent Developments/Updates
6.8 CHIESI Farmaceutici
6.8.1 CHIESI Farmaceutici Company Information
6.8.2 CHIESI Farmaceutici Description and Business Overview
6.8.3 CHIESI Farmaceutici Mesenchymal Stem Cell Injection Sales, Revenue and Gross Margin (2019-2024)
6.8.4 CHIESI Farmaceutici Mesenchymal Stem Cell Injection Product Portfolio
6.8.5 CHIESI Farmaceutici Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Mesenchymal Stem Cell Injection Industry Chain Analysis
7.2 Mesenchymal Stem Cell Injection Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Mesenchymal Stem Cell Injection Production Mode & Process
7.4 Mesenchymal Stem Cell Injection Sales and Marketing
7.4.1 Mesenchymal Stem Cell Injection Sales Channels
7.4.2 Mesenchymal Stem Cell Injection Distributors
7.5 Mesenchymal Stem Cell Injection Customers
8 Mesenchymal Stem Cell Injection Market Dynamics
8.1 Mesenchymal Stem Cell Injection Industry Trends
8.2 Mesenchymal Stem Cell Injection Market Drivers
8.3 Mesenchymal Stem Cell Injection Market Challenges
8.4 Mesenchymal Stem Cell Injection Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
ANTEROGEN CO LTD
PHARMICELL
MediPost Co Ltd
Osiris Therapeutics
Takeda
Stempeutics
JCR Pharmaceuticals
Chiesi Farmaceutici
List of Tables
 Table 1. Global Mesenchymal Stem Cell Injection Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global Mesenchymal Stem Cell Injection Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global Mesenchymal Stem Cell Injection Market Competitive Situation by Manufacturers in 2023
 Table 4. Global Mesenchymal Stem Cell Injection Sales (K Units) of Key Manufacturers (2019-2024)
 Table 5. Global Mesenchymal Stem Cell Injection Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global Mesenchymal Stem Cell Injection Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global Mesenchymal Stem Cell Injection Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market Mesenchymal Stem Cell Injection Average Price (US$/Unit) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of Mesenchymal Stem Cell Injection, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Mesenchymal Stem Cell Injection, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Mesenchymal Stem Cell Injection, Product Type & Application
 Table 12. Global Key Manufacturers of Mesenchymal Stem Cell Injection, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Mesenchymal Stem Cell Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mesenchymal Stem Cell Injection as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Mesenchymal Stem Cell Injection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global Mesenchymal Stem Cell Injection Sales by Region (2019-2024) & (K Units)
 Table 18. Global Mesenchymal Stem Cell Injection Sales Market Share by Region (2019-2024)
 Table 19. Global Mesenchymal Stem Cell Injection Sales by Region (2025-2030) & (K Units)
 Table 20. Global Mesenchymal Stem Cell Injection Sales Market Share by Region (2025-2030)
 Table 21. Global Mesenchymal Stem Cell Injection Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global Mesenchymal Stem Cell Injection Revenue Market Share by Region (2019-2024)
 Table 23. Global Mesenchymal Stem Cell Injection Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global Mesenchymal Stem Cell Injection Revenue Market Share by Region (2025-2030)
 Table 25. North America Mesenchymal Stem Cell Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America Mesenchymal Stem Cell Injection Sales by Country (2019-2024) & (K Units)
 Table 27. North America Mesenchymal Stem Cell Injection Sales by Country (2025-2030) & (K Units)
 Table 28. North America Mesenchymal Stem Cell Injection Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America Mesenchymal Stem Cell Injection Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe Mesenchymal Stem Cell Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe Mesenchymal Stem Cell Injection Sales by Country (2019-2024) & (K Units)
 Table 32. Europe Mesenchymal Stem Cell Injection Sales by Country (2025-2030) & (K Units)
 Table 33. Europe Mesenchymal Stem Cell Injection Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe Mesenchymal Stem Cell Injection Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific Mesenchymal Stem Cell Injection Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific Mesenchymal Stem Cell Injection Sales by Region (2019-2024) & (K Units)
 Table 37. Asia Pacific Mesenchymal Stem Cell Injection Sales by Region (2025-2030) & (K Units)
 Table 38. Asia Pacific Mesenchymal Stem Cell Injection Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific Mesenchymal Stem Cell Injection Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Mesenchymal Stem Cell Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America Mesenchymal Stem Cell Injection Sales by Country (2019-2024) & (K Units)
 Table 42. Latin America Mesenchymal Stem Cell Injection Sales by Country (2025-2030) & (K Units)
 Table 43. Latin America Mesenchymal Stem Cell Injection Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America Mesenchymal Stem Cell Injection Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa Mesenchymal Stem Cell Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa Mesenchymal Stem Cell Injection Sales by Country (2019-2024) & (K Units)
 Table 47. Middle East and Africa Mesenchymal Stem Cell Injection Sales by Country (2025-2030) & (K Units)
 Table 48. Middle East and Africa Mesenchymal Stem Cell Injection Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa Mesenchymal Stem Cell Injection Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global Mesenchymal Stem Cell Injection Sales (K Units) by Type (2019-2024)
 Table 51. Global Mesenchymal Stem Cell Injection Sales (K Units) by Type (2025-2030)
 Table 52. Global Mesenchymal Stem Cell Injection Sales Market Share by Type (2019-2024)
 Table 53. Global Mesenchymal Stem Cell Injection Sales Market Share by Type (2025-2030)
 Table 54. Global Mesenchymal Stem Cell Injection Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global Mesenchymal Stem Cell Injection Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global Mesenchymal Stem Cell Injection Revenue Market Share by Type (2019-2024)
 Table 57. Global Mesenchymal Stem Cell Injection Revenue Market Share by Type (2025-2030)
 Table 58. Global Mesenchymal Stem Cell Injection Price (US$/Unit) by Type (2019-2024)
 Table 59. Global Mesenchymal Stem Cell Injection Price (US$/Unit) by Type (2025-2030)
 Table 60. Global Mesenchymal Stem Cell Injection Sales (K Units) by Application (2019-2024)
 Table 61. Global Mesenchymal Stem Cell Injection Sales (K Units) by Application (2025-2030)
 Table 62. Global Mesenchymal Stem Cell Injection Sales Market Share by Application (2019-2024)
 Table 63. Global Mesenchymal Stem Cell Injection Sales Market Share by Application (2025-2030)
 Table 64. Global Mesenchymal Stem Cell Injection Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global Mesenchymal Stem Cell Injection Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global Mesenchymal Stem Cell Injection Revenue Market Share by Application (2019-2024)
 Table 67. Global Mesenchymal Stem Cell Injection Revenue Market Share by Application (2025-2030)
 Table 68. Global Mesenchymal Stem Cell Injection Price (US$/Unit) by Application (2019-2024)
 Table 69. Global Mesenchymal Stem Cell Injection Price (US$/Unit) by Application (2025-2030)
 Table 70. Anterogen Company Information
 Table 71. Anterogen Description and Business Overview
 Table 72. Anterogen Mesenchymal Stem Cell Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 73. Anterogen Mesenchymal Stem Cell Injection Product
 Table 74. Anterogen Recent Developments/Updates
 Table 75. Pharmicell Company Information
 Table 76. Pharmicell Description and Business Overview
 Table 77. Pharmicell Mesenchymal Stem Cell Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 78. Pharmicell Mesenchymal Stem Cell Injection Product
 Table 79. Pharmicell Recent Developments/Updates
 Table 80. Medipost Company Information
 Table 81. Medipost Description and Business Overview
 Table 82. Medipost Mesenchymal Stem Cell Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 83. Medipost Mesenchymal Stem Cell Injection Product
 Table 84. Medipost Recent Developments/Updates
 Table 85. Osiris Therapeutics Company Information
 Table 86. Osiris Therapeutics Description and Business Overview
 Table 87. Osiris Therapeutics Mesenchymal Stem Cell Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 88. Osiris Therapeutics Mesenchymal Stem Cell Injection Product
 Table 89. Osiris Therapeutics Recent Developments/Updates
 Table 90. Takeda Company Information
 Table 91. Takeda Description and Business Overview
 Table 92. Takeda Mesenchymal Stem Cell Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 93. Takeda Mesenchymal Stem Cell Injection Product
 Table 94. Takeda Recent Developments/Updates
 Table 95. Stempeutics Company Information
 Table 96. Stempeutics Description and Business Overview
 Table 97. Stempeutics Mesenchymal Stem Cell Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 98. Stempeutics Mesenchymal Stem Cell Injection Product
 Table 99. Stempeutics Recent Developments/Updates
 Table 100. JCR Pharmaceuticals Company Information
 Table 101. JCR Pharmaceuticals Description and Business Overview
 Table 102. JCR Pharmaceuticals Mesenchymal Stem Cell Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 103. JCR Pharmaceuticals Mesenchymal Stem Cell Injection Product
 Table 104. JCR Pharmaceuticals Recent Developments/Updates
 Table 105. CHIESI Farmaceutici Company Information
 Table 106. CHIESI Farmaceutici Description and Business Overview
 Table 107. CHIESI Farmaceutici Mesenchymal Stem Cell Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 108. CHIESI Farmaceutici Mesenchymal Stem Cell Injection Product
 Table 109. CHIESI Farmaceutici Recent Developments/Updates
 Table 110. Key Raw Materials Lists
 Table 111. Raw Materials Key Suppliers Lists
 Table 112. Mesenchymal Stem Cell Injection Distributors List
 Table 113. Mesenchymal Stem Cell Injection Customers List
 Table 114. Mesenchymal Stem Cell Injection Market Trends
 Table 115. Mesenchymal Stem Cell Injection Market Drivers
 Table 116. Mesenchymal Stem Cell Injection Market Challenges
 Table 117. Mesenchymal Stem Cell Injection Market Restraints
 Table 118. Research Programs/Design for This Report
 Table 119. Key Data Information from Secondary Sources
 Table 120. Key Data Information from Primary Sources
 Table 121. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Mesenchymal Stem Cell Injection
 Figure 2. Global Mesenchymal Stem Cell Injection Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Mesenchymal Stem Cell Injection Market Share by Type: 2023 & 2030
 Figure 4. Autologous Source Product Picture
 Figure 5. Allogeneic Source Product Picture
 Figure 6. Global Mesenchymal Stem Cell Injection Market Value by Application (2024-2030) & (US$ Million)
 Figure 7. Global Mesenchymal Stem Cell Injection Market Share by Application: 2023 & 2030
 Figure 8. Tissue Repair
 Figure 9. Immunomodulation
 Figure 10. Global Mesenchymal Stem Cell Injection Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 11. Global Mesenchymal Stem Cell Injection Market Size (2019-2030) & (US$ Million)
 Figure 12. Global Mesenchymal Stem Cell Injection Sales (2019-2030) & (K Units)
 Figure 13. Global Mesenchymal Stem Cell Injection Average Price (US$/Unit) & (2019-2030)
 Figure 14. Mesenchymal Stem Cell Injection Report Years Considered
 Figure 15. Mesenchymal Stem Cell Injection Sales Share by Manufacturers in 2023
 Figure 16. Global Mesenchymal Stem Cell Injection Revenue Share by Manufacturers in 2023
 Figure 17. Global 5 and 10 Largest Mesenchymal Stem Cell Injection Players: Market Share by Revenue in Mesenchymal Stem Cell Injection in 2023
 Figure 18. Mesenchymal Stem Cell Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 19. Global Mesenchymal Stem Cell Injection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 20. North America Mesenchymal Stem Cell Injection Sales Market Share by Country (2019-2030)
 Figure 21. North America Mesenchymal Stem Cell Injection Revenue Market Share by Country (2019-2030)
 Figure 22. United States Mesenchymal Stem Cell Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 23. Canada Mesenchymal Stem Cell Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 24. Europe Mesenchymal Stem Cell Injection Sales Market Share by Country (2019-2030)
 Figure 25. Europe Mesenchymal Stem Cell Injection Revenue Market Share by Country (2019-2030)
 Figure 26. Germany Mesenchymal Stem Cell Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 27. France Mesenchymal Stem Cell Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 28. U.K. Mesenchymal Stem Cell Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 29. Italy Mesenchymal Stem Cell Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 30. Russia Mesenchymal Stem Cell Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. Asia Pacific Mesenchymal Stem Cell Injection Sales Market Share by Region (2019-2030)
 Figure 32. Asia Pacific Mesenchymal Stem Cell Injection Revenue Market Share by Region (2019-2030)
 Figure 33. China Mesenchymal Stem Cell Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 34. Japan Mesenchymal Stem Cell Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 35. South Korea Mesenchymal Stem Cell Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 36. India Mesenchymal Stem Cell Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 37. Australia Mesenchymal Stem Cell Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. China Taiwan Mesenchymal Stem Cell Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. Southeast Asia Mesenchymal Stem Cell Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. Latin America Mesenchymal Stem Cell Injection Sales Market Share by Country (2019-2030)
 Figure 41. Mexico Mesenchymal Stem Cell Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 42. Brazil Mesenchymal Stem Cell Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 43. Argentina Mesenchymal Stem Cell Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 44. Colombia Mesenchymal Stem Cell Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 45. Middle East and Africa Mesenchymal Stem Cell Injection Sales Market Share by Country (2019-2030)
 Figure 46. Middle East and Africa Mesenchymal Stem Cell Injection Revenue Market Share by Country (2019-2030)
 Figure 47. Turkey Mesenchymal Stem Cell Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 48. Saudi Arabia Mesenchymal Stem Cell Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 49. UAE Mesenchymal Stem Cell Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 50. Global Sales Market Share of Mesenchymal Stem Cell Injection by Type (2019-2030)
 Figure 51. Global Revenue Market Share of Mesenchymal Stem Cell Injection by Type (2019-2030)
 Figure 52. Global Mesenchymal Stem Cell Injection Price (US$/Unit) by Type (2019-2030)
 Figure 53. Global Sales Market Share of Mesenchymal Stem Cell Injection by Application (2019-2030)
 Figure 54. Global Revenue Market Share of Mesenchymal Stem Cell Injection by Application (2019-2030)
 Figure 55. Global Mesenchymal Stem Cell Injection Price (US$/Unit) by Application (2019-2030)
 Figure 56. Mesenchymal Stem Cell Injection Value Chain
 Figure 57. Mesenchymal Stem Cell Injection Production Process
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

Global Mesenchymal Stem Cell Drugs Market Research Report 2024
Mesenchymal Stem Cells Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Mesenchymal Stem Cell Therapy MSCT Market Research Report 2025
Global Adipose Derived Stem Cell Therapy Market Research Report 2024
Global Osteoarthritis Cell Therapy Market Research Report 2024
Global Adipose Tissue derived Stem Cell Therapy Market Research Report 2024
Adipose Tissue Derived Stem Cell Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Human Mesenchymal Stem Cells hMSC Market Insights Forecast to 2030
Global Stem Cell Research Antibodies Market Research Report 2024
Global Stem Cell Therapy for Pets Market Research Report 2024
Global Stem Cell Therapy for Osteoarthritis Market Research Report 2024
Stem Cells Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Placental Stem Cell Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Musculoskeletal Disorder Stem Cell Therapy Market Insights Forecast to 2030
Global Rheumatoid Arthritis Stem Cell Therapy Market Research Report 2024
Global Pet Stem Cells Market Insights Forecast to 2030
Global Human Embryonic Stem Cells HESC Market Research Report 2024
Global Mesenchymal Stem Cell MSCs Therapeutic Product CDMO Service Market Research Report 2024
Global Stem Cell Therapy Market Insights Forecast to 2030
Global Osteoarthritis Chondrocyte Therapy Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions